Fast BioPharma

Fast BioPharma is a specialist Therapeutics company developing therapeutic antibodies in the field of Immuno-Oncology. Staffed by experienced Oncology executives, FasT BioPharma’s novel Antibodies leverage emerging biology such that the resulting therapeutic is expected to be active across a broad range of cancers. The company is at the preclinical stage.

BioCity invested in FasT because of the outstanding team and the significant interest in Immuno-Oncology which is anticipated to become a cornerstone of cancer treatment.